Cargando…

Clinical management of cerebral small vessel disease: a call for a holistic approach

Cerebral small vessel disease (SVD) is a common global brain disease that causes cognitive impairment, ischemic or hemorrhagic stroke, problems with mobility, and neuropsychiatric symptoms. The brain damage, seen as focal white and deep grey matter lesions on brain magnetic resonance imaging (MRI) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clancy, Una, Appleton, Jason P., Arteaga, Carmen, Doubal, Fergus N., Bath, Philip M., Wardlaw, Joanna M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817338/ https://www.ncbi.nlm.nih.gov/pubmed/33118960 http://dx.doi.org/10.1097/CM9.0000000000001177

Ejemplares similares

Neuropsychiatric symptoms as a sign of small vessel disease progression in cognitive impairment
por: Clancy, Una, et al.
Publicado: (2022)

Sex Differences in Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis
por: Jiménez-Sánchez, Lorena, et al.
Publicado: (2021)

Advanced Neuroimaging of Cerebral Small Vessel Disease
por: Blair, Gordon W., et al.
Publicado: (2017)

Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease
por: Wardlaw, Joanna, et al.
Publicado: (2020)

Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)
por: Bath, Philip M, et al.
Publicado: (2022)

Enlarged perivascular spaces and cerebral small vessel disease
por: Potter, Gillian M, et al.
Publicado: (2015)

Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions
por: Bath, Philip M., et al.
Publicado: (2015)

Impact of Small Vessel Disease Progression on Long-term Cognitive and Functional Changes After Stroke
por: Clancy, Una, et al.
Publicado: (2022)

Longitudinal Changes of White Matter Hyperintensities in Sporadic Small Vessel Disease: A Systematic Review and Meta-analysis
por: Jochems, Angela C.C., et al.
Publicado: (2022)

Retinal capillary microvessel morphology changes are associated with vascular damage and dysfunction in cerebral small vessel disease
por: Wiseman, Stewart J, et al.
Publicado: (2022)

Intracranial hemodynamic relationships in patients with cerebral small vessel disease
por: Blair, Gordon W., et al.
Publicado: (2020)

Advanced MRI in cerebral small vessel disease
por: van den Brink, Hilde, et al.
Publicado: (2022)

Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease
por: Wiseman, Stewart J, et al.
Publicado: (2015)

Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis
por: McHutchison, Caroline, et al.
Publicado: (2020)

The Application of Optical Coherence Tomography Angiography in Cerebral Small Vessel Disease, Ischemic Stroke, and Dementia: A Systematic Review
por: Zhang, Jun-Fang, et al.
Publicado: (2020)

MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease
por: Thrippleton, Michael J., et al.
Publicado: (2019)

ESO Guideline on covert cerebral small vessel disease
por: Wardlaw, Joanna M, et al.
Publicado: (2021)

ESO Guideline on covert cerebral small vessel disease
por: Wardlaw, Joanna M, et al.
Publicado: (2021)

Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden
por: Staals, Julie, et al.
Publicado: (2014)

Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial
por: Blair, Gordon W., et al.
Publicado: (2021)

A Comparison of CVR Magnitude and Delay Assessed at 1.5 and 3T in Patients With Cerebral Small Vessel Disease
por: Stringer, Michael S., et al.
Publicado: (2021)

Potential recruitment into a clinical trial of vascular secondary prevention medications in cerebral small vessel disease, based on concomitant medication use
por: Morrison, Edward, et al.
Publicado: (2021)

Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial
por: Wardlaw, Joanna M., et al.
Publicado: (2023)

Small Vessel Disease and Dietary Salt Intake: Cross-Sectional Study and Systematic Review
por: Makin, Stephen D.J., et al.
Publicado: (2017)

Are neuropsychiatric symptoms a marker of small vessel disease progression in older adults? Evidence from the Lothian Birth Cohort 1936
por: Clancy, Una, et al.
Publicado: (2022)

Zooming in on cerebral small vessel function in small vessel diseases with 7T MRI: Rationale and design of the “ZOOM@SVDs” study
por: van den Brink, Hilde, et al.
Publicado: (2021)

Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study
por: Sleight, Emilie, et al.
Publicado: (2023)

Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3
por: Clancy, Una, et al.
Publicado: (2020)

Relationship Between Venules and Perivascular Spaces in Sporadic Small Vessel Diseases
por: Jochems, Angela C.C., et al.
Publicado: (2020)

Effects of Isosorbide Mononitrate and/or Cilostazol on Hematological Markers, Platelet Function, and Hemodynamics in Patients With Lacunar Ischaemic Stroke: Safety Data From the Lacunar Intervention-1 (LACI-1) Trial
por: Appleton, Jason P., et al.
Publicado: (2019)

Interhemispheric characterization of small vessel disease imaging markers after subcortical infarct
por: Valdés Hernández, Maria del C., et al.
Publicado: (2016)

Update on cerebral small vessel disease: a dynamic whole-brain disease
por: Shi, Yulu, et al.
Publicado: (2016)

Retinal microvasculature and cerebral small vessel disease in the Lothian Birth Cohort 1936 and Mild Stroke Study
por: McGrory, Sarah, et al.
Publicado: (2019)

Early life characteristics and late life burden of cerebral small vessel disease in the Lothian Birth Cohort 1936
por: Field, Thalia S., et al.
Publicado: (2016)

The effect of different combinations of vascular, dependency and cognitive endpoints on the sample size required to detect a treatment effect in trials of treatments to improve outcome after lacunar and non-lacunar ischaemic stroke
por: Makin, Stephen DJ, et al.
Publicado: (2017)

How Much Do Focal Infarcts Distort White Matter Lesions and Global Cerebral Atrophy Measures?
por: Wang, Xin, et al.
Publicado: (2012)

Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke
por: Appleton, Jason P., et al.
Publicado: (2020)

Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel Disease
por: Rudilosso, Salvatore, et al.
Publicado: (2022)

Cerebral Small Vessel Disease and Renal Function: Systematic Review and Meta-Analysis
por: Makin, Stephen D.J., et al.
Publicado: (2015)

Intracranial Bleeding After Reperfusion Therapy in Acute Ischaemic Stroke Patients Randomized to Glyceryl Trinitrate vs. Control: An Individual Patient Data Meta-Analysis
por: Appleton, Jason P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ep26c483nvg10veqiaioi04sq1